Prof. Komuro to Issue Objection to Chiba University in Wake of Second Retraction Request Related to VART Study

Issei Komuro, professor of the University of Tokyo (formerly of Chiba University), who led Chiba University’s VART study involving Novartis Pharma’s angiotensin receptor blocker Diovan (valsartan), plans to issue an objection as early as this week to Chiba University. The...read more